Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis
Epilepsia · 2024
DOI: 10.1111/epi.18087 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, 2024. Verfasst von Emanuele Cerulli Irelli und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Neurosciences, Sapienza University, Rome, Italy. Hauptthemen laut MEDLINE: Levetiracetam, Lamotrigine, Bayes Theorem, Anticonvulsants. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Objective
Women of childbearing age with juvenile absence epilepsy (JAE) face treatment challenges due to limited access to safe and effective anti‐seizure medications (ASMs). In a previous study we compared the effectiveness of levetiracetam (LEV) and lamotrigine (LTG) in women with idiopathic generalized epilepsy (IGE), highlighting a superiority of LEV in juvenile myoclonic epilepsy. In this study, we specifically reanalyzed, through a Bayesian approach and by expanding the previously published cohort, the comparative effectiveness of these ASMs as initial monotherapy in JAE.
Methods
We conducted a multicenter, retrospective, comparative effectiveness study on women of childbearing age diagnosed with JAE and prescribed LEV or LTG as the initial ASM. Inverse probability treatment weighting (IPTW) Bayesian Cox proportional hazard models were employed to evaluate treatment failure (TF) due to ineffectiveness and ASM retention. The patients’ center of provenance and year of prescription were considered as random effect factors. Posterior probabilities and relative log‐risk distribution were computed, and the distribution of posterior draws was analyzed to assess the evidence supporting LTG superiority over LEV.
Results
Of 123 patients, those treated with LTG ( n = 67) demonstrated lower TF and higher ASM retention than those treated with LEV ( n = 56), with the IPTW‐weighted Bayesian Cox proportional hazards model showing a 99.2% posterior probability of LTG being superior on TF and a 99.5% probability on ASM retention. Additional analyses on ≥50% and ≥75% seizure reduction through IPTW‐weighted Bayesian logistic regression largely confirmed these findings, whereas the two ASMs did not show evident differences in terms of seizure freedom. The two ASMs showed comparable safety profiles, with only a minority of patients discontinuing treatment due to side effects. Significance Bayesian reanalysis supports LTG as first‐line monotherapy for JAE in women of childbearing age, emphasizing the importance of individualized treatment strategies in women with IGE. This study underscores the value of Bayesian methods in refining clinical research and treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Neurosciences, Sapienza University, Rome, Italy.
- Department of Precision Medicine and Genomics, Columbia University, New York, New York, USA.
- Department of Medicine, Columbia University, New York, New York, USA.
- Department of Neurology, Odense University Hospital, Odense, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Neurology, Beaumont Hospital, Dublin, Ireland.
ORCID-Profile: Emanuele Cerulli Irelli, Enrico Cocchi, Javier Peña-Ceballos, Roberto H Caraballo, Simona Lattanzi, Patrick B Moloney, Angelo Pascarella, Chiara Pizzanelli, Chiara Milano, Loretta Giuliano, Norman Delanty, Antonio Gambardella, Angelo Labate, Francesca F Operto, Christoph P Beier, Carlo Di Bonaventura
Zitieren
APA
Cerulli Irelli, E., Cocchi, E., Gesche, J., Peña-Ceballos, J., Caraballo, R. H., Lattanzi, S., Strigaro, G., Orlando, B., Moloney, P. B., Catania, C., Ferlazzo, E., Pascarella, A., Casciato, S., Pizzanelli, C., Milano, C., Giuliano, L., Viola, V., Mostacci, B., Fortunato, F., …, & Di Bonaventura, C. (2024). Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis. Epilepsia. https://doi.org/10.1111/epi.18087
Vancouver
Cerulli Irelli E, Cocchi E, Gesche J, Peña-Ceballos J, Caraballo RH, Lattanzi S, et al. Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis. Epilepsia. 2024. doi:10.1111/epi.18087
BibTeX
@article{CerulliIrelli2024,
author = {Cerulli Irelli, Emanuele and Cocchi, Enrico and Gesche, Joanna and Peña-Ceballos, Javier and Caraballo, Roberto H and Lattanzi, Simona and Strigaro, Gionata and Orlando, Biagio and Moloney, Patrick B and Catania, Cecilia and Ferlazzo, Edoardo and Pascarella, Angelo and Casciato, Sara and Pizzanelli, Chiara and Milano, Chiara and Giuliano, Loretta and Viola, Veronica and Mostacci, Barbara and Fortunato, Francesco and Pulitano, Patrizia and Rosati, Eleonora and Perulli, Marco and Delanty, Norman and Di Gennaro, Giancarlo and Gambardella, Antonio and Labate, Angelo and Operto, Francesca F and Giallonardo, Anna T and Baykan, Betul and Beier, Christoph P and Women with Epilepsy Treatment Options and Research (WETOR) study group, Women with Epilepsy Treatment Options and Research (WETOR) study group and Di Bonaventura, Carlo},
title = {Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis},
journal = {Epilepsia},
year = {2024},
doi = {10.1111/epi.18087}
}
EUVIMED